RudaCure Inc. attends the Global Bio Expo BIO USA 2024
RudaCure Inc. (hereinafter "RudaCure"), a company specializing in the development of treatments for 眼部 diseases and 慢性疼痛, attended the '国际生物技术大会 2024' (hereinafter "BIO USA") held in 圣迪亚哥, USA from June 3 to June 6. BIO USA is the world's largest 生物技术 industry expo, offering a comprehensive view of the latest trends and innovative technologies in the global bio industry.
At this expo, RudaCure showcased its latest R&D achievements and technological capabilities while exploring opportunities to build global partnerships and collaborations. In particular, RudaCure's key products—干眼症治疗药 (RCI001) and 角膜溃疡 treatment (RCI001U)—drew significant attention from attendees.
Throughout the event, RudaCure conducted business meetings with a variety of global 制药 and 生物科技 companies, engaging in discussions on 技术转让 and joint R&D. Through these interactions, RudaCure aims to strengthen its position in the 全球市场 and enhance its international competitiveness.
RudaCure plans to grow into a global bio制药公司 that contributes to improving human health and quality of life through continuous R&D and innovation. This participation in BIO USA is expected to further solidify RudaCure's standing in the global bio market and mark an important turning point for the company's future growth.